305 related articles for article (PubMed ID: 30905487)
1. Antimicrobial treatment challenges in the era of carbapenem resistance.
Peri AM; Doi Y; Potoski BA; Harris PNA; Paterson DL; Righi E
Diagn Microbiol Infect Dis; 2019 Aug; 94(4):413-425. PubMed ID: 30905487
[TBL] [Abstract][Full Text] [Related]
2. Management of carbapenem-resistant Enterobacteriaceae infections.
Durante-Mangoni E; Andini R; Zampino R
Clin Microbiol Infect; 2019 Aug; 25(8):943-950. PubMed ID: 31004767
[TBL] [Abstract][Full Text] [Related]
3. Emerging antibiotic resistance: carbapenemase-producing enterobacteria. Bad new bugs, still no new drugs.
Spera AM; Esposito S; Pagliano P
Infez Med; 2019 Dec; 27(4):357-364. PubMed ID: 31846984
[TBL] [Abstract][Full Text] [Related]
4. Treatment for carbapenem-resistant Enterobacterales infections: recent advances and future directions.
Tompkins K; van Duin D
Eur J Clin Microbiol Infect Dis; 2021 Oct; 40(10):2053-2068. PubMed ID: 34169446
[TBL] [Abstract][Full Text] [Related]
5. Personalised randomised controlled trial designs-a new paradigm to define optimal treatments for carbapenem-resistant infections.
Walker AS; White IR; Turner RM; Hsu LY; Yeo TW; White NJ; Sharland M; Thwaites GE
Lancet Infect Dis; 2021 Jun; 21(6):e175-e181. PubMed ID: 33894130
[TBL] [Abstract][Full Text] [Related]
6. Options for treating carbapenem-resistant Enterobacteriaceae.
Rafailidis PI; Falagas ME
Curr Opin Infect Dis; 2014 Dec; 27(6):479-83. PubMed ID: 25259809
[TBL] [Abstract][Full Text] [Related]
7. Repurposing Zidovudine in combination with Tigecycline for treating carbapenem-resistant Enterobacteriaceae infections.
Ng SMS; Sioson JSP; Yap JM; Ng FM; Ching HSV; Teo JWP; Jureen R; Hill J; Chia CSB
Eur J Clin Microbiol Infect Dis; 2018 Jan; 37(1):141-148. PubMed ID: 29019016
[TBL] [Abstract][Full Text] [Related]
8. Rapid Increase in Prevalence of Carbapenem-Resistant Enterobacteriaceae (CRE) and Emergence of Colistin Resistance Gene
Li Y; Sun QL; Shen Y; Zhang Y; Yang JW; Shu LB; Zhou HW; Wang Y; Wang B; Zhang R; Wang S; Shen Z
J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29386265
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic options for carbapenem-resistant Enterobacteriaceae infections.
Trecarichi EM; Tumbarello M
Virulence; 2017 May; 8(4):470-484. PubMed ID: 28276996
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of invasive carbapenemase-producing Enterobacteriaceae infections in children using carbapenem-aminoglycoside combination therapy: A case series.
Williams PCM; Bartlett AW; Palasanthiran P; Armstrong B; McMullan BJ
Infect Dis Health; 2020 Nov; 25(4):314-318. PubMed ID: 32698988
[TBL] [Abstract][Full Text] [Related]
11. An update on the management of urinary tract infections in the era of antimicrobial resistance.
Bader MS; Loeb M; Brooks AA
Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
[TBL] [Abstract][Full Text] [Related]
12. Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes.
van Duin D; Kaye KS; Neuner EA; Bonomo RA
Diagn Microbiol Infect Dis; 2013 Feb; 75(2):115-20. PubMed ID: 23290507
[TBL] [Abstract][Full Text] [Related]
13. Carbapenem and colistin resistance in children with Enterobacteriaceae infections.
Haytoğlu Z; Gündeşlioğlu ÖÖ; Yıldızdaş D; Kocabaş E; Alabaz D; Horoz ÖÖ
Turk J Pediatr; 2020; 62(5):778-786. PubMed ID: 33108080
[TBL] [Abstract][Full Text] [Related]
14. Carbapenem-Containing Combination Antibiotic Therapy against Carbapenem-Resistant Uropathogenic
Loose M; Link I; Naber KG; Wagenlehner FME
Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31636073
[TBL] [Abstract][Full Text] [Related]
15. Colistin-sparing approaches with newer antimicrobials to treat carbapenem-resistant organisms: Current evidence and future prospects.
Veeraraghavan B; Pragasam AK; Bakthavatchalam YD; Anandan S; Swaminathan S; Sundaram B
Indian J Med Microbiol; 2019; 37(1):72-90. PubMed ID: 31424014
[TBL] [Abstract][Full Text] [Related]
16. The management of multidrug-resistant Enterobacteriaceae.
Bassetti M; Peghin M; Pecori D
Curr Opin Infect Dis; 2016 Dec; 29(6):583-594. PubMed ID: 27584587
[TBL] [Abstract][Full Text] [Related]
17. Leveraging antimicrobial stewardship into improving rates of carbapenem-resistant Enterobacteriaceae.
Wong D; Spellberg B
Virulence; 2017 May; 8(4):383-390. PubMed ID: 27187821
[TBL] [Abstract][Full Text] [Related]
18. Carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii: assessing their impact on organ transplantation.
Patel G; Perez F; Bonomo RA
Curr Opin Organ Transplant; 2010 Dec; 15(6):676-82. PubMed ID: 20930636
[TBL] [Abstract][Full Text] [Related]
19. Carbapenem-Resistant Enterobacteriaceae: An update narrative review from Saudi Arabia.
Alotaibi F
J Infect Public Health; 2019; 12(4):465-471. PubMed ID: 31060974
[TBL] [Abstract][Full Text] [Related]
20. The rapid spread of carbapenem-resistant Enterobacteriaceae.
Potter RF; D'Souza AW; Dantas G
Drug Resist Updat; 2016 Nov; 29():30-46. PubMed ID: 27912842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
